FTH
Faeth Therapeutics, Inc.
24.90$
-7.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -8.9% | -10.3% | -10.3% | -10.9% | -14.8% | -15.6% | -17.0% | -13.2% | -17.0% | +796.8% | -7.8% | |
| – | -8.9% | -10.4% | -10.4% | -10.8% | -12.8% | -14.9% | -17.1% | -12.8% | -16.6% | +849.6% | -7.6% | |
| – | +14.7% | -15.8% | +8.5% | +60.9% | -47.8% | -1.2% | +27.1% | -15.9% | -17.9% | +1,657.3% | -82.3% | |
| – | -8.7% | -11.7% | -10.0% | -10.1% | -12.1% | -16.9% | -16.6% | -12.5% | -15.4% | +857.3% | -8.1% | |
| – | -11.1% | -13.3% | -7.5% | -1.7% | -6.7% | -9.9% | -28.9% | +2.5% | -5.9% | +229.3% | +15.2% | |
| – | -9.4% | -11.5% | -0.9% | +9.9% | +0.1% | -4.0% | -25.9% | +14.5% | -4.2% | +233.8% | -32.5% | |
| – | +1.4% | +1.6% | -0.9% | -0.9% | -4.8% | -7.2% | -8.7% | -4.5% | -22.7% | -28.3% | -43.0% | |
| – | -37.9% | +18.1% | -17.7% | +1.8% | -85.4% | +48.0% | -2.8% | -12.8% | +125.2% | +396.1% | -37.2% | |
| – | -8.6% | -9.9% | -10.7% | -12.3% | -16.1% | -16.7% | -14.6% | -15.8% | -19.2% | +928.3% | -9.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -1.9% | +0.1% | +0.2% | +0.2% | +0.1% | +0.1% | +0.1% | +0.0% | +0.0% | +2.7% | +335.8% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.